In line with improved barrier function, various studies have shown the beneficial effects of the anti-diabetic compound metformin, acting through AMPK-dependent and -independent mechanisms [13,14], on dextran sulfate sodium (DSS)-induced colitis in mice [15,16,17,18]. Here, PRKAA2 is linked to colitis.